SCHEMBL21311648

SCHEMBL21311648

O=C(O)[C@@H]1CCC[C@H](c2cccc(C(F)(F)F)c2)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.51
▸ AKR1C1 Q04828 1/20 0.51
▸ HTR2C P28335 3/20 0.50
▸ NOTUM Q6P988 1/20 0.48
▸ POLB P06746 1/20 0.46
▸ GRM2 Q14416 1/20 0.44
▸ GRM3 Q14832 1/20 0.44
▸ DRD2 P14416 1/20 0.43
▸ IDH2 P48735 1/20 0.43
▸ GRIN2B Q13224 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ S1PR5 Q9H228 2/20 0.42
▸ S1PR1 P21453 1/20 0.42
▸ GRK5 P34947 1/20 0.42
▸ CDK8 P49336 1/20 0.42
▸ DGAT1 O75907 1/20 0.42
▸ KMO O15229 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21311649 1.00 AKR1C3 (0.51) AKR1C3AKR1C1HTR2CNOTUMPOLB
SCHEMBL31154443 0.92 AKR1C3 (0.62) AKR1C3AKR1C1HTR2CNOTUMGRM2
SCHEMBL31154407 0.92 AKR1C3 (0.62) AKR1C3AKR1C1HTR2CNOTUMGRM2
SCHEMBL2532290 0.81 HTR2C (0.72) HTR2CDRD2HTR2AHTR2B
SCHEMBL1072981 0.79 AKR1C3 (0.79) AKR1C3AKR1C1
SCHEMBL10177724 0.79 AKR1C3 (0.79) AKR1C3AKR1C1
SCHEMBL16457233 0.77 HTR2C (0.72) HTR2CDRD2KMOHTR2AHTR2B
SCHEMBL21311688 0.77 HTR2C (0.55) HTR2CDRD2HTR2AHTR2B
SCHEMBL20095988 0.77 HTR2C (0.55) HTR2CDRD2HTR2AHTR2B
SCHEMBL21311601 0.77 HTR2C (0.55) HTR2CDRD2HTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019165290-A1 PYRIDINE-SULFONAMIDE COMPOUNDS AND THEIR USE AGAINST PAIN AND RELATED CONDITIONS GENENTECH, INC. (US) 2019-08-29 — — WO disclosed
Send feedback